SyB D-0701

· SymBio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SyB D-0701, covering 2014-11-19 to 2014-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV) [Phase 2]